Objective: Although B-type natriuretic peptide (BNP) concentrations seem to be useful for detecting the presence of patent ductus arteriosus, there is no information about their usefulness for monitoring changes in PDA shunt magnitude.
Introduction
More than 30% of preterm infants born before 32 weeks of gestation have a patent ductus arteriosus (PDA) that fails to close after birth. In preterm infants, a PDA alters mesenteric blood flow, impairs pulmonary mechanics, increases the risk of pulmonary hemorrhage and prolongs the need for mechanical ventilation. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The echocardiogram has been used as a gold standard for determining the presence of a PDA and for evaluating temporal changes in the magnitude of a PDA left-to-right shunt. Unfortunately, frequent echocardiographic studies can destabilize an infant, may not be readily available in all institutions and increase hospital costs.
B-type natriuretic peptide (BNP) is a vasoregulatory peptide that is synthesized mainly in the cardiac ventricles. BNP is released into the circulation in response to increases in cardiac volume, pressure loading and following ventricular stress. 11 BNP concentrations have been shown to be an excellent screening tool for differentiating cardiac from noncardiac causes of dyspnea in adults, with sensitivities and specificities that are reported to surpass those of clinical and radiological methods. [12] [13] [14] [15] Numerous studies suggest that elevated BNP concentrations may be useful for detecting the presence of a PDA in premature neonates. [16] [17] [18] [19] [20] [21] [22] Recently, several authors have suggested that by using BNP measurements to monitor changes in PDA shunt magnitude, the need for repeated echocardiography may be obviated. Although BNP concentrations decrease to levels comparable to those in preterm infants without a PDA following successful treatment and elimination of the left-to-right shunt, 23, 21 no studies to date have reported on the ability of BNP measurements to detect worsening or increasing degrees of shunt magnitude.
Since 2004, BNP measurements have been used (in addition to clinical and echocardiographic examinations) to evaluate and monitor preterm patients with a PDA in the William H. Tooley Nursery at the University of California San Francisco. We carried out a retrospective analysis of paired BNP and echocardiographic measurements to determine how well BNP measurements reflect changes in PDA shunt magnitude. We hypothesized that changes in serial BNP concentrations would accurately reflect the changes in PDA shunt magnitude (determined by echocardiography) that occur over the same time period.
Methods

Patient population
This project was approved by the Institutional Review Board of the University of California San Francisco. We performed a retrospective analysis to determine the accuracy of BNP measurements in (1) detecting and determining the magnitude of a PDA shunt and (2) in monitoring changes (either increases or decreases) in PDA shunt magnitude. Between January 2004 and May 2008, 797 infants, with gestational ages between 24 and 32 weeks, were admitted to the nursery. Echocardiograms and BNP measurements were ordered by the attending neonatologist to evaluate a known or suspected PDA. Infants qualified for the study by having at least one BNP-echocardiogram pair (defined as a BNP concentration measured on the same day as an echocardiogram). Infants were excluded from the study if they were <5 days old at the time of measurement or if they had congenital anomalies or congenital heart disease, pulmonary hypertension, hypotension requiring vasopressor support, documented sepsis, necrotizing enterocolitis or serum creatinine >2.0 mg per 100 ml, as these conditions have been associated with increased BNP concentrations. 16-18,24 -31 The echocardiographic studies included two-dimensional imaging, M-mode, color flow mapping and Doppler interrogation as previously described. 32 Echocardiographic indices were obtained from standard subxiphoidal, precordial, apical and suprasternal imaging windows using standard imaging transducers (Sequoia ultrasound system, Siemens Medical Solutions, Mountain View, CA, USA). Results were recorded for subsequent analysis. A single cardiologist (TT), blinded to clinical and BNP data, re-read all the original echocardiograms. The ductus arteriosus was scored as either closed or open; if open, the left-to-right shunt was scored as small, moderate or large. The magnitude of the left-to-right shunt was scored subjectively by the cardiologist based on the presence of a combination of echocardiographic measures previously described as reflective of the degree of PDA shunt: ductus diameter X1.5 mm, left atrium-to-aortic root ratio X1.5, diastolic flow velocity in the left pulmonary artery >0.2 m s À1 and presence of holodiastolic reversal of flow in the descending aorta (at the level of the diaphragm). 16, [33] [34] [35] Venous blood samples for BNP were sent to the Central Laboratory of the Hospital and assayed within 2 h of collection using the Triage BNP assay (Biosite Diagnostics, San Diego, CA, USA). The assay detects BNP concentrations between 5 and 5000 pg ml À1 . The average total imprecision of the assay (determined by testing control blood samples that had BNP added to concentrations throughout the range of the standard curve) was p12%. BNP concentrations in normal adults (without congestive heart failure) are reported to be p40 pg ml À1 in our Central Laboratory.
Statistics
Statistical analysis was carried out using Stata version 10 (Stata, College Park, TX, USA). Continuous variables with nonparametric distribution were compared using the Wilcoxon rank sum test; categorical variables were compared with the w 2 -test as well as univariate and multivariate logistic regression. Box and whisker plots were used to show the distribution of BNP levels. All hypotheses were two tailed. Our specific aims were to determine the accuracy of BNP measurements in (1) detecting and determining the magnitude of a PDA shunt and (2) in monitoring changes (either increases or decreases) in PDA shunt magnitude.
For specific aim 1, the sensitivities, specificities and likelihood ratios of various BNP concentrations were calculated for diagnosing either a 'large' or a 'moderate-or-large PDA' shunt. Receiver-operator characteristic (ROC) curves were constructed to determine the discriminating power of using BNP to detect moderate-or-large PDA shunts.
For specific aim 2, our primary clinical interest was to determine how well an increase in BNP concentration over time could identify a PDA shunt that was worsening (that is, increasing in shunt magnitude) during the same time period. We wanted to know how well an increase in BNP concentration could differentiate a worsening PDA shunt from PDA shunts that were stable or improving. Sensitivities, specificities, likelihood ratios and ROC curves were constructed to determine the discriminating power of various increases in serial BNP concentrations to diagnose an increase in shunt magnitude.
We also examined the ability of a decrease in BNP concentration over time to identify a PDA shunt that was getting better (that is, decreasing in shunt magnitude during the same time period). Sensitivities, specificities, likelihood ratios and ROC curves were constructed to determine the discriminating power of various decreases in serial BNP concentrations to differentiate a PDA shunt that was improving from PDA shunts that were stable or deteriorating.
Results
Patient demographics
Altogether, 88 infants qualified for the study and a total of 146 BNP-echocardiogram pairs were analyzed (Table 1) . On the basis of the echocardiogram, the ductus arteriosus was subjectively scored as either closed (n ¼ 23) or open (n ¼ 123); if open, the left-to-right shunt was scored as small (n ¼ 47), moderate (n ¼ 28) or large (n ¼ 48). Table 1 shows the distribution of echocardiographic indicators (that reflect the magnitude of PDA shunt flow 16,33 -35 ) among the different PDA shunt groups (closed, small, moderate or large shunts).
Accuracy of BNP in diagnosing a large or a moderate-or-large PDA shunt In all, 48% of the paired BNP-echocardiogram measurements were made in the presence of a closed or small PDA; 52% were made in the presence of a moderate-or-large PDA shunt (Table 1) . BNP concentrations were significantly related to the magnitude of the PDA shunt (Figure 1 ). For any shunt magnitude, the BNP concentrations were significantly greater than those of smaller shunts and significantly less than those of larger shunts. In logistic regression analyses, BNP concentrations were significantly associated with the presence of either 'large' or 'moderate-or-large' PDA shunts. The association was independent of other variables (gestation, birth weight, gender and postnatal age at the time of measurement) (adjusted odds ratio for 'moderate-to-large' PDA shunt with every 100 pg ml À1 increase in BNP ¼ 2.81, 95%
confidence interval 1.79 to 4.40, P<0.001; for 'large' PDA shunt with every 100 pg ml À1 increase in BNP adjusted odds ratio ¼ 1.44 (95% confidence interval: 1.23 to 1.68), P ¼ 0.000). Table 2 depicts the sensitivities, specificities and likelihood ratios of various BNP concentrations in diagnosing either a 'large' or a 'moderate-or-large PDA' shunt. We used ROC analysis to determine the discriminating power of using BNP to detect moderate-or-large PDA shunts. In general, one expects that the area under an ROC curve should be >0.90 for a test to be considered excellent in its ability to discriminate one condition from another; tests with areas between 0.90 and 0.80 are considered good; tests with areas below 0.80 are considered to have fair discriminating ability; and those with areas below 0.70 are considered to be poor. The area under the ROC curve for detection of a 'moderate-or-large' PDA was 0.85, and for the detection of a 'large' PDA was 0.84.
Accuracy of BNP changes as a reflection of changes in PDA shunt magnitude To determine whether changes in BNP measurements over time accurately reflect changes in PDA shunt magnitude, we examined serial BNP-echocardiogram pairs in infants who had more than one BNP-echocardiogram pair measured during their hospitalization. In total, 91 serial BNP-echocardiogram pairs were examined in 36 infants.
Our primary clinical interest was to determine how well an increase in BNP concentration over time could identify a PDA shunt that was worsening (that is, increasing in shunt magnitude) during the same time period. We wanted to know how well an increase in BNP concentration could differentiate a worsening PDA shunt from PDA shunts that were stable or improving. We also wanted to examine the ability of a decrease in BNP concentration over time to identify a PDA shunt that was getting better (that is, decreasing in shunt magnitude during the same time period). A PDA shunt was considered to have increased in size if the shunt magnitude increased from (a) a closed ductus lumen to a small, moderate or large shunt, (b) a small shunt to a moderate or large shunt or (c) a moderate shunt to a large shunt. Changes in the opposite direction were used to define a decrease in shunt size. Changes in BNP concentration were expressed as the percent change from the initial BNP measurement. As the imprecision of the BNP assay is p12%, we considered any increase or decrease in BNP concentration of <15% to be no change. Figure 2 shows the relationship between a change in PDA shunt magnitude (either an increase, a decrease or no change) and the change in BNP concentration during the same interval. The change in BNP concentration (between the first and second measurement) was significantly higher when the PDA shunt increased in magnitude, than when it was either unchanged or decreased in magnitude. Conversely, the change in BNP concentration was significantly lower when the shunt decreased in size, than when it was either unchanged or increased in size (Figure 2) .
In logistic regression analyses, increases in BNP concentration were significantly associated with increases in PDA shunt magnitude, and decreases in BNP concentration were significantly associated with decreases in PDA shunt magnitude. These associations were independent of other variables (gestation, birth weight, gender and postnatal age at the time of measurement) (adjusted odds ratio for an increase in PDA shunt magnitude with an increase in BNP concentration was 9.63, 95% confidence interval 2.87 to 32.35, P<0.001; adjusted odds ratio for a decrease in PDA shunt magnitude with a decrease in BNP concentration was 4.93, 95% confidence interval 1.44 to 16.88, P ¼ 0.01).
We generated ROC curves to determine the clinical utility of using changes in BNP concentration to predict changes in PDA shunt magnitude. Using increases in BNP concentration to predict increases in PDA shunt magnitude, the area under the ROC curve was 0.76. Using decreases in BNP concentration to predict decreases in PDA shunt magnitude, the area under the ROC curve was 0.78. Table 3 lists sensitivities, specificities and likelihood ratios for various changes in BNP concentrations.
Using the absolute change in BNP concentration as our discriminating test (rather than the percent change in BNP concentration) did not alter our findings (data not shown).
Discussion
Our results are consistent with previous studies that found that BNP concentrations are significantly related to the magnitude of a PDA shunt (Figure 1) . [16] [17] [18] [19] [20] [21] [22] However, despite this significant association, Abbreviations: BNP, B-type natriuretic peptide; PDA, patent ductus arteriosus. Legend: N ¼ 146 BNP-echocardiogram pairs (from 88 infants). Likelihood ratios (LRs) are reflective of the inherent ability of a test to increase or decrease the likelihood of a condition. An LR þ of >1 means that a positive test result will increase the patient's probability of having a moderate-or-large PDA shunt. An LR-of <1 means that a negative test result will decrease the patient's probability of having a moderate-or-large PDA shunt. In general, an LR+ of >10, or an LR-of <0.1 indicate that the test has an excellent chance of identifying the correct condition. LRs of 5-10 or 0.1-0.2 only have a good chance of identifying the correct condition. BNP concentrations seem to have, at best, only a good ability to discriminate between moderate-to-large shunts and those that are small-or-closed. We should point out that, although a single BNP value is not an excellent test for determining PDA shunt magnitude, having a BNP concentration p40 pg ml À1 indicates that there is an extremely low likelihood that a large left-to-right PDA shunt is present.
Other investigators have observed a decrease in BNP concentrations following pharmacological or surgical PDA closure 23, 19, 21 and have suggested that serial BNP measurements may be used to monitor changes in PDA shunt magnitude. As none of the previous studies reported about either the ability of BNP measurements to detect spontaneously closing PDAs or PDAs that were developing worsening shunts (increasing degrees of shunt magnitude), we examined the accuracy of using serial measurements of BNP to monitor changes in PDA shunt magnitude. We were particularly interested in the ability of serial BNP measurements to discriminate between PDA shunts that were progressively getting larger and those that were stable or decreasing in magnitude. As the imprecision of the BNP assay is <12%, we assumed that a change in BNP concentration X15% would be the most sensitive discriminator for identifying a change in PDA shunt magnitude. We found that any decrease in BNP concentration of X15% only detects 82% of the PDA shunts that decreased in magnitude during the same interval (Table 3) . Increases in BNP concentration were even less sensitive in their ability to detect increases in shunt magnitude; any increase in BNP concentration of X15% only detected 59% of PDA shunts that increased in magnitude during the same interval. The areas under the ROC curves reveal that both increases and decreases in BNP concentrations should be considered only fair indications that there have been concurrent increases and decreases in shunt magnitude, respectively.
Plasma BNP has a half-life of 20 min. 36 In our study, the echocardiogram and whole-blood BNP measurements were carried out at different times and therefore may not have reflected the same hemodynamic state. However, the evaluations were carried out on the same day that the neonatologists were concerned that a symptomatic PDA might be present. The difference in times between the tests reflects the normal delays that occur in common clinical practice in a busy intensive care environment. It is unlikely that the difference between the measurements is due to rapid fluctuations in steady state hemodynamics. We observed two infants in whom the BNP concentrations steadily declined over three weekly measurements at the same time that the echocardiographic measurements of PDA shunt size changed in the opposite direction (from moderate to very largeFwith ventricular dilatation and mitral regurgitation). This asynchrony (between changes in BNP and echocardiographic shunt measurements) has been observed by others. 21 Why some neonates have low BNP concentrations despite a large hemodynamically significant shunt is still unclear. 19, 37 Recently, the N-terminal by-product of BNP formation, N-terminal proBNP, has been used to detect the presence of a PDA.
11 Future studies will be needed to evaluate the usefulness of N-terminal proBNP measurements for predicting changes in PDA shunt magnitude.
In conclusion, we found that although BNP concentrations were significantly related to PDA shunt magnitude, the high degree of variability in the measurements made them less useful for monitoring changes in magnitude. The ROC curves reveal that increases and decreases in BNP concentration have only fair predictive ability in determining the direction of change in shunt magnitude.
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The comparisons between increases in serial BNP concentrations and increases in PDA shunt magnitude were made by comparing the binary variable increase in BNP (increase in BNP versus decrease or no change in BNP) with the binary variable increase in PDA shunt (increase in shunt versus decrease or no change in shunt). Similarly, the comparisons between decreases in serial BNP concentrations and decreases in PDA shunt magnitude were made by comparing the binary variable decrease in BNP (decrease in BNP versus increase or no change in BNP) with the binary variable decrease in PDA shunt (decrease in shunt versus increase or no change in shunt).
